Described herein are pharmaceutical packaging systems which prevent oxidative degradation of morphine, hydromorphone, promethazine along with other oxygen-delicate drugs, such programs like a syringe with the oxygen permeable idea cap, a hermetically sealed oxygen barrier blister packaging with really low permeability to oxygen and comprises ethyle